The heterogeneity of lung cancer cells in expressing Src kinase activity and dependence of Src activation in regulation of cell growth may be differentially responsive to Src inhibition and also differentially vulnerable to Src activation and development of EGFR TKI resistance. This evidence concerns the gene EGFR and lung carcinoma.